Company / Interest Expense per Share
Oncology Institute, Inc. Interest Expense per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.06
FY2023
5-year range
-$0.06 / $0.00
FY2021-FY2023
Trend
-1175.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed -1175% YoY in FY2023, a notable deviation from the 2-year average annual change of -684%.
Based on SEC 10-K filings.
-0.06 in FY2023.
Improved from $0.00 to $-0.06 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense per share decreased 1175.3% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.06 | -1175.3% |
| FY2022 | -$0.00 | -192.2% |
| FY2021 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026